Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Rybelsus“
Suchtreffer
Begriffe & Kennungen
Rybelsus · 4.5 · Interactions with medicinal products with very low bioavailability (1%) have not been evaluated.
Eintrag öffnenRybelsus · 4.5 · Omeprazole No clinically relevant change in AUC or Cmax of semaglutide was observed when taken with omeprazole
Eintrag öffnenRybelsus · 4.5 · Omeprazole No clinically relevant change in AUC or Cmax of semaglutide was observed when taken with omeprazole
Eintrag öffnenRybelsus · 4.5 · Rosuvastatin AUC of rosuvastatin was increased by 41% [90% CI: 24; 60] when co-administered with semaglutide.
Eintrag öffnenRybelsus · 4.5 · Rosuvastatin AUC of rosuvastatin was increased by 41% [90% CI: 24;60] when co-administered with semaglutide. B
Eintrag öffnenRybelsus · 4.5 · Semaglutide delays gastric emptying which may influence the absorption of other oral medicinal products.
Eintrag öffnenRybelsus · 4.5 · Semaglutide delays gastric emptying which may influence the absorption of other oral medicinal products.
Eintrag öffnenRybelsus · 4.5 · Thyroxine Total exposure (Area Under the Curve (AUC)) of thyroxine (adjusted for endogenous levels) was increa
Eintrag öffnenRybelsus · 4.5 · Thyroxine Total exposure (Area Under the Curve (AUC)) of thyroxine (adjusted for endogenous levels) was increa
Eintrag öffnenRybelsus · 4.5 · Warfarin and other coumarin derivatives Semaglutide did not change the AUC or Cmax of R- and S-warfarin follow
Eintrag öffnenRybelsus · 4.5 · Warfarin and other coumarin derivatives Semaglutide did not change the AUC or Cmax of R- and S-warfarin follow
Eintrag öffnenRybelsus · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenRybelsus · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenRybelsus · 4.8 Undesirable effects · 1
Eintrag öffnenRybelsus · 4.8 Undesirable effects · 2
Eintrag öffnenRybelsus · 4.8 · 31 78 weeks. The most frequently reported adverse reactions in clinical trials were gastrointestinal disorders
Eintrag öffnenRybelsus · 4.8 · 32 MedDRA Very Common Uncommon Rare Very Not system organ common Rare known class reflux disease Flatulence He
Eintrag öffnenRybelsus · 4.8 · 33 Diabetic retinopathy complications A 2-year clinical trial with subcutaneous semaglutide investigated 3 297
Eintrag öffnenRybelsus · 4.8 · 7 78 weeks. The most frequently reported adverse reactions in clinical trials were gastrointestinal disorders,
Eintrag öffnenRybelsus · 4.8 · 8 MedDRA Very Common Uncommon Rare Very Not system organ common Rare known class reflux disease Flatulence Hep
Eintrag öffnen